NASDAQ:IVF INVO Fertility (IVF) Stock Price, News & Analysis $0.74 +0.00 (+0.35%) Closing price 10/8/2026 04:00 PM EasternExtended Trading$0.76 +0.02 (+2.96%) As of 05:49 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsInsider TradesNews and TrendsOwnershipSEC Filings About INVO Fertility Stock (NASDAQ:IVF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get INVO Fertility alerts:Sign Up Key Stats Today's Range$0.74▼$0.7650-Day Range$0.74▼$1.5352-Week Range$0.71▼$84.40Volume69,664 shsAverage Volume139,744 shsMarket Capitalization$1.86 millionP/E RatioN/ADividend YieldN/APrice Target$20.00Consensus RatingModerate Buy Company Overview INVO Fertility, Inc. (NASDAQ: IVF) is a fertility-care company focused on expanding access to in vitro fertilization (IVF) through its INVO Procedure and related medical technology. The company develops, manufactures and commercializes INVOcell, an FDA-cleared medical device designed to provide a controlled environment for fertilizing and incubating embryos inside a woman’s body, as an alternative to conventional laboratory-based embryo culture. The INVO Procedure uses INVOcell as part of an assisted-reproductive treatment process that can be offered by fertility specialists and clinics. INVO Fertility also supports the development and operation of fertility centers, including clinics using its technology, with the goal of providing more accessible and potentially lower-cost fertility services. The company was formerly known as INVO Bioscience and adopted the INVO Fertility name as its business expanded from medical-device development toward a broader fertility-services model. Its activities have included commercial and clinical efforts in the United States and international markets through partnerships, distributors and fertility-center operations. The company’s offerings are intended for patients and providers seeking alternatives to traditional IVF laboratory infrastructure.AI Generated. May Contain Errors. Read More INVO Fertility Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks42nd Percentile Overall ScoreIVF MarketRank™: INVO Fertility scored higher than 42% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingModerate Buy Consensus RatingINVO Fertility has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, no buy ratings, no hold ratings, and 1 sell rating.Upside PotentialINVO Fertility has a consensus price target of $20.00, representing about 2,602.3% upside from its current price of $0.74.Amount of Analyst CoverageINVO Fertility has only been the subject of 1 research reports in the past 90 days.Read more about INVO Fertility's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of INVO Fertility is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of INVO Fertility is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioINVO Fertility has a P/B Ratio of 0.21. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted7.76% of the float of INVO Fertility has been sold short.Short Interest Ratio / Days to CoverINVO Fertility has a short interest ratio ("days to cover") of 1.39, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in INVO Fertility has recently decreased by 47.30%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldINVO Fertility does not currently pay a dividend.Dividend GrowthINVO Fertility does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A MarketBeat Follows3 people have added INVO Fertility to their MarketBeat watchlist in the last 30 days. Company Ownership0.2 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, INVO Fertility insiders have not sold or bought any company stock.Percentage Held by Insiders0.43% of the stock of INVO Fertility is held by insiders.Percentage Held by Institutions12.02% of the stock of INVO Fertility is held by institutions.Read more about INVO Fertility's insider trading history. Receive IVF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for INVO Fertility and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IVF Stock News HeadlinesINVO Fertility, Inc (NASDAQ:IVF) Sees Significant Decline in Short InterestSeptember 29, 2026 | americanbankingnews.comINVO Fertility to Participate in Lytham Partners Fall 2026 Investor ConferenceSeptember 25, 2026 | quiverquant.comQHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required. | Stansberry Research (Ad)INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor ConferenceSeptember 25, 2026 | globenewswire.comINVO Fertility Announces Equity Financing and Capital CommitmentAugust 29, 2026 | theglobeandmail.comINVO Fertility to Participate in H.C. Wainwright's 28th Annual Global Investment ConferenceAugust 28, 2026 | globenewswire.comINVO Fertility Announces Five Poster Presentations Highlighting Platelet-Rich Plasma Research at the 2026 Midwest Reproductive Symposium InternationalAugust 20, 2026 | globenewswire.comINVO Fertility Stock Surges Following Q2 Earnings BeatAugust 17, 2026 | benzinga.comSee More Headlines IVF Stock Analysis - Frequently Asked Questions How have IVF shares performed this year? INVO Fertility's stock was trading at $3.7630 at the beginning of the year. Since then, IVF stock has decreased by 80.3% and is now trading at $0.7401. How were INVO Fertility's earnings last quarter? INVO Fertility, Inc (NASDAQ:IVF) issued its earnings results on Friday, August, 14th. The company reported $0.35 earnings per share (EPS) for the quarter. The firm had revenue of $2.18 million for the quarter. INVO Fertility had a negative trailing twelve-month return on equity of 85.54% and a negative net margin of 116.29%. When did INVO Fertility's stock split? INVO Fertility shares reverse split on Friday, November 28th 2025.The 1-8 reverse split was announced on Tuesday, November 25th 2025. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 26th 2025. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split. How do I buy shares of INVO Fertility? Shares of IVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/14/2026Today10/08/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (46m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 IVF's financial health is in the Red zone, according to TradeSmith. IVF has been in this zone for over 46 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:IVF Previous SymbolNASDAQ:INVO CIK1417926 Webwww.invobioscience.com Phone(978) 878-9505FaxN/AEmployees46Year Founded2009Price Target and Rating Average Price Target for INVO Fertility$20.00 High Price Target$20.00 Low Price Target$20.00 Potential Upside/Downside+2,602.3%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($33.83) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$25.13 million Net Margins-116.29% Pretax Margin-93.56% Return on Equity-85.54% Return on Assets-31.05% Debt Debt-to-Equity Ratio0.03 Current Ratio0.71 Quick Ratio0.67 Sales & Book Value Annual Sales$7.53 million Price / Sales0.25 Cash FlowN/A Price / Cash FlowN/A Book Value$3.46 per share Price / Book0.21Miscellaneous Outstanding Shares2,507,000Free Float2,496,000Market Cap$1.86 million OptionableNo Data Beta2.39 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NASDAQ:IVF) was last updated on 10/9/2026 by MarketBeat.com Staff. From Our PartnersTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredYour withdrawal order could cost you in taxesIf you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Fertility, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share INVO Fertility With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
